Xijuan Liu Selected Research

Xijuan Liu Research Topics

Disease

18	Neoplasms (Cancer) 01/2023 - 02/2014
4	Melanoma (Melanoma, Malignant) 06/2020 - 01/2017
3	Triple Negative Breast Neoplasms 11/2022 - 11/2016
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2022 - 11/2016
3	Experimental Melanoma 06/2020 - 01/2017
2	Hypoxia (Hypoxemia) 01/2023 - 01/2022
2	Lung Neoplasms (Lung Cancer) 01/2022 - 11/2016
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 01/2018
2	Stomach Neoplasms (Stomach Cancer) 09/2016 - 11/2015
1	Osteosarcoma (Osteogenic Sarcoma) 01/2023
1	Precocious Puberty 01/2022
1	Lymphatic Metastasis 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Carcinogenesis 01/2022
1	AIDS-Related Complex (ARC) 08/2021
1	Liver Neoplasms (Liver Cancer) 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Hypertrophy 12/2020
1	Spondylosis 12/2020
1	Carcinoma (Carcinomatosis) 05/2020
1	Kidney Neoplasms (Kidney Cancer) 01/2020
1	Breast Neoplasms (Breast Cancer) 01/2019
1	B-Cell Lymphoma (Lymphoma, B Cell) 11/2016
1	Infections 01/2016
1	Virus Diseases (Viral Diseases) 01/2016
1	Hematologic Neoplasms (Hematological Malignancy) 01/2015
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2014
1	Persistent Infection 11/2013

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2016
3	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2022 - 01/2018
2	MicroRNAs (MicroRNA)IBA 01/2022 - 08/2021
2	EnzymesIBA 01/2022 - 11/2019
2	Long Noncoding RNAIBA 12/2020 - 05/2020
2	Messenger RNA (mRNA)IBA 12/2020 - 01/2016
2	Transcription Factors (Transcription Factor)IBA 01/2018 - 01/2015
2	LigandsIBA 11/2016 - 02/2014
2	Cisplatin (Platino)FDA LinkGeneric 11/2016 - 09/2016
1	Oxygen (Dioxygen)IBA 01/2023
1	CateninsIBA 11/2022
1	osimertinibIBA 09/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Small Interfering RNA (siRNA)IBA 01/2022
1	Growth Hormone (Somatotropin)IBA 01/2022
1	Angiopoietin-like ProteinsIBA 01/2022
1	Ketoglutaric Acids (Ketoglutaric Acid)IBA 01/2022
1	snake venom protein C activatorIBA 01/2022
1	Collagen Type XIBA 08/2021
1	Sorafenib (BAY 43-9006)FDA Link 01/2021
1	Circular RNAIBA 12/2020
1	Competitive Endogenous RNAIBA 12/2020
1	ResveratrolIBA 06/2020
1	Proteolysis Targeting ChimeraIBA 01/2020
1	Leucine (L-Leucine)FDA Link 01/2020
1	AntigensIBA 01/2020
1	Adenylosuccinate LyaseIBA 11/2019
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 11/2019
1	Mixed Function Oxygenases (Monooxygenases)IBA 11/2019
1	Thymidine KinaseIBA 01/2019
1	CurcuminIBA 01/2019
1	Ganciclovir (Cytovene)FDA LinkGeneric 01/2019
1	MicellesIBA 01/2019
1	ConnexinsIBA 01/2017
1	SaponinsIBA 01/2017
1	dioscinIBA 01/2017
1	GlucosidesIBA 01/2017
1	Connexin 43 (Connexin43)IBA 01/2017
1	Caspase 8 (Caspase-8)IBA 11/2016
1	RNA (Ribonucleic Acid)IBA 11/2016
1	xihuangIBA 11/2016
1	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 11/2016
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 11/2016
1	Caspase 3 (Caspase-3)IBA 11/2016
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2016
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 09/2016
1	Tyrosine Kinase InhibitorsIBA 09/2016
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 09/2016
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2016
1	Fluorouracil (Carac)FDA LinkGeneric 09/2016
1	famitinibIBA 09/2016
1	Chemokine CCL5IBA 01/2016
1	Trastuzumab (Herceptin)FDA Link 11/2015
1	dactolisibIBA 11/2015
1	GATA2 Transcription FactorIBA 01/2015
1	CD20 AntigensIBA 12/2014
1	obinutuzumabIBA 12/2014
1	Monoclonal AntibodiesIBA 12/2014
1	Viral AntigensIBA 11/2013
1	Viral RNAIBA 11/2013

Therapy/Procedure

4	Therapeutics 01/2023 - 10/2017
3	Drug Therapy (Chemotherapy) 01/2022 - 11/2016
1	Diskectomy (Discectomy) 12/2020
1	Aftercare (After-Treatment) 11/2016
1	Adjuvant Chemotherapy 11/2016